Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash $ 38,883,569 $ 1,858,513
Account receivable, net of allowance of $257,463 as of December 31, 2020   831,390
Prepaid expenses and other current assets 6,350,889 240,352
Total current assets 45,234,458 2,930,255
Other assets 15,921 10,914
Total assets 45,250,379 2,941,169
Current liabilities:    
Accounts payable (includes $0 and $149,067 due to related parties) 5,559,412 3,153,310
Accrued and other current liabilities 1,995,961 1,728,483
Accrued clinical site costs 1,154,042 1,547,432
Earnout Cash liability 26,283,238  
Warrant liabilities 775,263  
Notes payable and accrued interest 515,059 248,861
Accrued settlement expense   39,486,139
Total current liabilities 36,282,975 46,164,225
Notes payable and accrued interest   547,827
Total liabilities 36,282,975 46,712,052
Stockholders' equity (deficit):    
Preferred stock
Common stock, $0.001 par value, 500,000,000 shares authorized; 0 and 42,973,462 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively 54,810 42,974
Additional paid-in capital 161,362,260 46,365,863
Accumulated deficit (152,449,666) (90,179,720)
Total stockholders' equity (deficit) 8,967,404 (43,770,883)
Total liabilities and stockholders' equity $ 45,250,379 $ 2,941,169